References
- Esposito S, Leone S, Carosi G. Analysis of current guidelines for intra-abdominal infections. J Chemother. 2009;21(Suppl 1):30–35.
- Esposito S, Leone S, Noviello S. Management of severe bacterial infections. Expert Rev Anti Infect Ther. 2005;3(4):593–600.
- Leone S, Stefani S, Venditti M, et al; Italian Intra-abdominal Infections Working Group. Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial options. Int J Antimicrob Agents. 2011;38(3):271–272.
- Kontoyiannis DP, Luna MA, Samuels BI, Bodey GP. Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis. Infect Dis Clin North Am. 2000;14(3):721–739.
- Bodey GP. Fungal infections complicating acute leukemia. J Chronic Dis. 1966;19(6):667–687.
- Bodey GP, DeJongh D, Isassi A, Freireich EJ. Hypersplenism due to disseminated candidiasis in a patient with acute leukemia. Cancer. 1969;24(2):417–420.
- De Castro N, Mazoyer E, Porcher R, et al. Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000–2007. Clin Microbiol Infect. 2012;18(6):e185–e187.
- Cornely OA, Maertens J, Winston DJ, et al. Posaconazole versus. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007;356(4):348–359.
- Vehreschild JJ, Böhme A, Buchheidt D, et al. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukemia (AML). J Infect. 2007;55(5):445–449.
- Anttila VJ, Elonen E, Nordling S, Sivonen A, Ruutu T, Ruutu P. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis. 1997;24(3):375–380.
- Sallah S, Semelka RC, Wehbie R, Sallah W, Nguyen NP, Vos P. Hepatosplenic candidiasis in patients with acute leukemia. Br J Haematol. 1999;106(3):697–701.
- Pagano L, Mele L, Fianchi L, et al. Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes. Haematologica. 2002;87(5):535–541.
- Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34(1):7–14.
- Chen CY, Chen YC, Tang JL, et al. Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis. Ann Hematol. 2003;82(2):93–97.
- De Pauw B, Walsh TJ, Donnelly JP, et al; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813–1821.
- Sallah S, Wan JY, Nguyen NP, Vos P, Sigounas G. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study. Cancer. 2001;92(6):1349–1353.
- Vazquez L. Antifungal prophylaxis in immunocompromised patients. Mediterr J Hematol Infect Dis. 2016;8(1):e2016040.
- Leventakos K, Lewis RE, Kontoyiannis DP. Fungal infections in leukemia patients: how do we prevent and treat them? Clin Infect Dis. 2010;50(3):405–415.
- Cadena J, Thompson GR 3rd, Patterson TF. Invasive aspergillosis: current strategies for diagnosis and management. Infect Dis Clin North Am. 2016;30(1):125–142.
- van der Velden WJ, Blijlevens NM, Klont RR, Donnelly JP, Verweij PE. Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder. Ann Hematol. 2006;85(9):621–623.
- Chasan R, Patel G, Malone A, Finn M, Huprikar S. Primary hepatic aspergillosis following induction chemotherapy for acute leukemia. Transpl Infect Dis. 2013;15(3):e201–e205.
- Esposito S, Carosi G, Leone S. Intra-abdominal infections: analysis of current guidelines. Infez Med. 2008;16(Suppl 1):46–52.
- Rusthoven JJ, Feld R, Tuffnell PG. Systemic infection by Rhodotorula spp. in the immunocompromised host. J Infect. 1984;8(3):241–246.
- Bhaskaran A, Obeid KM, Arbefeville S, Ferrieri P. Trichosporon loubieri fungemia in a 39-year-old Caucasian woman with B-cell lymphoblastic leukemia. Lab Med. 2016;47(3):255–258.
- Amft N, Miadonna A, Viviani MA, Tedeschi A. Disseminated Geotrichum capitatum infection with predominant liver involvement in a patient with non Hodgkin’s lymphoma. Haematologica. 1996;81(4):352–355.
- Liu PY, Yang Y, Shi ZY. Cryptococcal liver abscess: a case report of successful treatment with amphotericin-B and literature review. Jpn J Infect Dis. 2009;62(1):59–60.
- Suzuki T, Ichiki Y, Kamihira T, et al. [A case of hepatic cryptococcosis complicated by adult T-cell leukemia]. Nihon Shokakibyo Gakkai Zasshi. 2015;112(12):2168–75. Japanese.
- Khan AA, Kumaran V, Jain D, Siraj F, Aggarwal S. Hepatic mucormycosis in a patient of acute lymphoblastic leukemia: a case report with literature review. Indian J Hematol Blood Transfus. 2013;29(2):96–98.
- Oliver MR, Van Voorhis WC, Boeckh M, Mattson D, Bowden RA. Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Clin Infect Dis. 1996;22(3):521–524.
- Ng VL, Yajko DM, Hadley WK. Extrapulmonary pneumocystosis. Clin Microbiol Rev. 1997;10(3):4014–4018.
- Cordonnier C, Cesaro S, Maschmeyer G, et al. Pneumocystis jirovecii pneumonia: still a concern in patients with hematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2379–2385.
- Lublin M, Bartlett DL, Danforth DN, et al. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg. 2002;235(3):383–391.
- Marciano BE, Spalding C, Fitzgerald A, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60(8):1176–1183.
- Mamishi S, Zomorodian K, Saadat F, Gerami-Shoar M, Tarazooie B, Siadati SA. A case of invasive aspergillosis in CGD patient successfully treated with Amphotericin B and INF- gamma. Ann Clin Microbiol Antimicrob. 2005;4:4.
- Kulaksiz H, Rudolph G, Kloeters-Plachky P, Sauer P, Geiss H, Stiehl A. Biliary candida infections in primary sclerosing cholangitis. J Hepatol. 2006;45(5):711–716.
- Lima R, Shams W, Kalra S, Borthwick T. Candida glabrata liver abscess and fungemia complicating severe acalculus cholecystitis in an immunocompetent non diabetic host. South Med J. 2010;103(3):245–247.
- Lai CH, Chen HP, Chen TL, Fung CP, Liu CY, Lee SD. Candidal liver abscesses and cholecystitis in a 37-year-old patient without underlying malignancy. World J Gastroenterol. 2005;11(11):1725–1727.
- Friedman E, Blahut RJ, Bender MD. Hepatic abscesses and fungemia from Torulopsis glabrata. Successful treatment with percutaneous drainage and amphotericin B. J Clin Gastroenterol. 1987;9(6):711–715.
- Melero JL, Bastida G, Yago M, Nevarez A, Nos P, Ponce J. Fungal liver abscesses in a patient with primary sclerosing cholangitis and Crohn’s disease. Gastroenterol Hepatol. 2008;31(9):576–579.
- Erdman SH, Barber BJ, Barton LL. Aspergillus cholangitis: a late complication after Kasai portoenterostomy. J Pediatr Surg. 2002;37(6):923–925.
- Ioannidis JP, Snydman DR, Rohrer RJ, Freeman RB, Haug CE. Aspergillus fumigatus infection of a bilioma. Clin Infect Dis. 1995;20(5):1427–1428.
- Hassan HA, Majid RA, Rashid NG, et al. Eosinophilic granulomatous gastrointestinal and hepatic abscesses attributable to basidiobolomycosis and fasciolias: a simultaneous emergence in Iraqi Kurdistan. BMC Infect Dis. 2013;13:91.
- van den Berk GE, Noorduyn LA, van Ketel RJ, et al. A fatal pseudo-tumor: disseminated basidiobolomycosis. BMC Infect Dis. 2006;6:140.
- Greenberg RG, Benjamin DK Jr. Neonatal candidiasis: diagnosis, prevention, and treatment. J Infect. 2014;69(Suppl 1):19–22.
- Sharma D, Choudhary M, Shastri S, Sharma PK. Neonatal liver abscesses due to Candida infection in a preterm infant, secondary to malpositioned umbilical lines – a rare entity. Pathog Glob Health. 2015;109(2):84–87.
- Picone S, Manzoni P, Bedetta M, Mostert M, Benjamin DK Jr, Paolillo P. Pharmacological resolution of a multiloculated Candida spp. liver abscess in a preterm neonate. Early Hum Dev. 2013;89(Suppl 1):47–50.
- Pammi M, Holland L, Butler G, Gacser A, Bliss JM. Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis. Pediatr Infect Dis J. 2013;32(5):e206–e216.
- Ozkaya-Parlakay A, Tezer H, Kazmacan T, Gulhan B, Unal S. Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin. J Trop Pediatr. 2014;60(4):329–330.
- Trachana M, Roilides E, Gompakis N, Kanellopoulou K, Mpantouraki M, Kanakoudi-Tsakalidou F. Case report. Hepatic abscesses due to Aspergillus terreus in an immunodeficient child. Mycoses. 2001;44(9–10):415–418.
- Geramizadeh B, Sanai Dashti A, Kadivar MR, Kord S. Isolated hepatic basidiobolomycosis in a 2-year-old girl: the first case report. Hepat Mon. 2015;15(8):e30117.
- Annunziata GM, Blackstone M, Hart J, Piper J, Baker AL. Candida (Torulopsis glabrata) liver abscesses eight years after orthotopic liver transplantation. J Clin Gastroenterol. 1997;24(3):176–179.
- Fortún J, López-San Román A, Velasco JJ, et al. Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis. Eur J Clin Microbiol Infect Dis. 1997;16(4):314–318.
- Alexander J, Limaye AP, Ko CW, Bronner MP, Kowdley KV. Association of hepatic iron overload with invasive fungal infection in liver transplant recipients. Liver Transpl. 2006;12(12):1799–1804.
- Snydman DR. The potential role for iron overload and fungal infection in liver transplantation. Liver Transpl. 2006;12(12):1731–1732.
- Musso M, Giannella M, Antonini M, et al. Invasive Candidiasis due to Candida Norvegensis in a Liver Transplant patient: case report and literature review. Infect Dis Rep. 2014;6(29):5374.
- Mazza D, Gugenheim J, Toouli J, Mouiel J. Survival of a liver graft recipient treated for an aspergillar liver abscess. Clin Infect Dis. 1996;23(4):831–832.
- Vucicevic D, Carey EJ, Blair JE. Coccidioidomycosis in liver transplant recipients in an endemic area. Am J Transplant. 2011;11(1):111–119.
- Parish JM, Blair JE. Coccidioidomycosis. Mayo Clin Proc. 2008;83(3):343–348.
- Abboud CS, Bergamasco MD, Baía CES, et al. Case report of hepatic mucormycosis after liver transplantation: successful treatment with liposomal amphotericin B followed by posaconazole sequential therapy. Transplant Proc. 2012;44(8):2501–2502.
- Davari HR, Malekhossini SA, Salahi HA, et al. Outcome of mucormycosis in liver transplantation: four cases and a review of literature. Exp Clin Transplant. 2003;1(2):147–152.
- Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009;48(12):1743–1751.
- Alvarez OA, Vanegas F, Maze GL, Gross GW, Lee M. Polymicrobial cholangitis and liver abscess in a patient with the acquired immunodeficiency syndrome. South Med J. 2000;93(2):232–234.
- Cazorla A, Alanio A, Bretagne S, et al. Cryptococcus where they are not expected: Five case reports of extra-cerebral and extra-pulmonary cryptococcosis. Ann Pathol. 2015;35(6):479–485.
- Pattullo V. Prevention of Hepatitis B reactivation in the setting of immunosuppression. Clin Mol Hepatol. 2016;22:219–237.
- Coluccio C, Begini P, Marzano A, et al. Hepatitis B in patients with hematological diseases: an update. World J Hepatol. 2017;9(25):1043–1053.
- Averbuch D, Orasch C, Cordonnier C, et al; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013;98(12):1826–1835.
- Moreno A, Cervera C, Gavaldá J, et al. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant. 2007;7:2579–2586.
- Gustinetti G, Mikulska M. Bloodstream infections in neutropenic cancer patients: a practical update. Virulence. 2016;7(3):280–297.
- Cornely OA, Gachot B, Akan H, et al; EORTC Infectious Diseases Group. Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin Infect Dis. 2015;61(3):324–331.
- Pagano L, Busca A, Candoni A, et al; SEIFEM (Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne) Group. Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations. Blood Rev. 2017;31(2):17–29.
- Esposito S, Capuano A, Noviello S, et al. Modification of patients’ endogenous bacterial flora during hospitalization in a large teaching hospital in Naples. J Chemother. 2003;15(6), 568–573.
- Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1–e50.
- Fiore M, Leone S. Use of anti-fungals in critically ill cirrhotic patients with spontaneous peritonitis. J Hepatol. 2016;64(4):986–987.
- Fiore M, Andreana L, Leone S. Pre-emptive therapy of spontaneous fungal peritonitis. Hepatology. 2016;64(3):997–998.
- Fiore M, Leone S. Spontaneous fungal peritonitis: epidemiology, current evidence and future prospective. World J Gastroenterol. 2016;22(34):7742–7747.
- Fiore M, Chiodini P, Pota V, et al. Risk of spontaneous fungal peritonitis (SFP) in hospitalized cirrhotic patients with ascites: a systematic review of observational studies and meta-analysis. Minerva Anestesiol. Epub 2017 Jul 20.
- Fiore M, Maraolo AE, Leone S, et al. Spontaneous peritonitis in critically ill cirrhotic patients: a diagnostic algorithm for clinicians and future perspectives. Ther Clin Risk Manag. 2017;13:1409–1414.
- Ghosh S, Sharma S, Gadpayle AK, et al. Clinical, laboratory, and management profile in patients of liver abscess from northern India. J Trop Med. 2014;2014:142382.
- Petri A, Hohn J, Hodi Z, Wolfard A, Balogh A. Pyogenic liver abscess – 20 years’ experience. Comparison of results of treatment in two periods. Langenbecks Arch Surg. 2002;387(1):27–31.
- Menachery J, Chawla Y, Chakrabarti A, Duseja A, Dhiman R, Kalra N. Fungal liver abscess in an immunocompetent individual. Trop Gastroenterol. 2012;33(3):232–233.
- Kornasiewicz O, Hołówko W, Grat M, et al. Hepatic abscess: a rare complication after liver transplant. Clin Transplant. 2016;30(10):1230–1235.
- Giannella M, Bartoletti M, Morelli M, et al. Antifungal prophylaxis in liver transplant recipients: one size does not fit all. Transpl Infect Dis. 2016;18(4):538–544.
- Fìlice C, Brunetti E, Bruno R, Crippa FG. Clinical management of hepatic abscesses in HIV patients. Am J Gastroenterol. 2000;95(4):1092–1093.
- Leone S, Gregis GP, Quinzan GP, et al. Causes of death and risk factors among HIV-infected persons in HAART era: analysis of a large urban cohort. Infection. 2011;39(1):13–20.